Can Elevated Pretreatment Serum Carcinoembryonic Antigen Levels Serve as a Potential Biomarker Guiding Adjuvant Chemotherapy in Rectal Cancer Patients With ypTis-3N0 After Neoadjuvant Radiotherapy and Surgery?

Survival benefit of adjuvant chemotherapy (ACT) remained controversial in patients with stage II/III rectal cancer (RC) who received neoadjuvant therapy and surgery. This study aimed to investigate the guiding role of elevated pretreatment serum carcinoembryonic antigen (CEA) levels for receiving AC...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chi, Jiang, Mingkun, Li, Yan, Tang, Chaoyang, Ma, Xiang, Huan, Xiangkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369410/
https://www.ncbi.nlm.nih.gov/pubmed/34414115
http://dx.doi.org/10.3389/fonc.2021.705460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369410/
https://www.ncbi.nlm.nih.gov/pubmed/34414115
http://dx.doi.org/10.3389/fonc.2021.705460

Ejemplares similares